Helicos Secures Bridge Loan, Abandons Plans for CLIA Lab as Cash Position Weakens, Revenues Fall

With a cash position of $1.9 million as of Nov. 10, Helicos has reduced its headcount and has dropped plans to develop its own CLIA-certified genetic testing lab.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.